To date, the IHC characterization of MMR proteins expression represents a pivotal screening tool in the identification of patients with suspected Lynch syndrome (LS), a cancer predisposition syndrome inherited in an autosomal dominant manner and due to germline pathogenic variants in MMR genes [3,5,6,7]. This evidence concerns the gene MRC1 and Leigh syndrome.